| | View this message online 
Hello manoj kumar valluru, An interesting paper was published last week in the journal Stem Cells demonstrating inhibition of kidney failure using syngeneic bone marrow stem cells. The company Allocure is in clinical trials using bone marrow for similar conditions. Of patents issued last week, #7,465,582 teaches how to induce dopaminergic differentiation of neural progenitor cells by coculture with astrocytes. #7,465,442 discloses methods of inhibiting scar tissue formation by gene therapy with the cyclin dependent kinase inhibitor p21... ...and just a treat for the Holiday Season, #7,465,551 covers ways of determining how much G-CSF to give to a patient based on the concentration of G-CSF they have in circulation. Our "blogging brothers" and Patently-O describe a very interesting case regarding a patent on determining effects of immunization on chronic disease...it may be interesting to read the discussion for that case after you read 7,465,551.
The 3rd Annual Stem Cells World Congress (20-22 January 2009)
The Stem Cell Meeting (March 2009)
Thanks again for your help in supporting StemCellPatents.com.
We welcome your comments and suggestions! Tell us here.
Media Partnerships (NEW)
NEW -  (BETA) Now you can send our newsletters to your friends and colleagues using our quick and easy send-to-a-friend feature (BETA).
------------------------------------------------------------ To unsubscribe, click here. Delivered: Tuesday December 23rd, 2008 @ 15:15:33 EST | |
